RIZFIRSA

Serial Number 99128100
Registration 8032566
700

Registration Progress

Application Filed
Apr 9, 2025
Under Examination
Approved for Publication
Sep 30, 2025
Published for Opposition
Sep 30, 2025
Registered
Nov 18, 2025

Trademark Image

RIZFIRSA

Basic Information

Serial Number
99128100
Registration Number
8032566
Filing Date
April 9, 2025
Registration Date
November 18, 2025
Published for Opposition
September 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 18, 2025
Registration
Registered
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG12NY
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Stevenage GB

Glaxo Group Limited

Owner at Publication
99
Stevenage GB

Glaxo Group Limited

Original Registrant
99
Stevenage GB

Legal Representation

Attorney
Christopher M. Hanes

USPTO Deadlines

Next Deadline
2146 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251118)
Due Date
November 18, 2031
Grace Period Ends
May 18, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Nov 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 30, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 30, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 24, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 28, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2025 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jul 24, 2025 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Apr 9, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification

International Classes
005